ETFs most similar to IBRN
The funds whose holdings overlap iShares Neuroscience and Healthcare ETF the most, by weight. as of Oct 8, 2026issuer data
By holdings overlap
| Fund | Category | Overlap with IBRN | Fee | Assets | 1Y | Yield | Compare |
|---|---|---|---|---|---|---|---|
| IBRNiShares Neuroscience and Healthcare ETF | Biotech & Health Innovation | — | 0.47% | $6.4M | +13.3% | 1.01% | |
| SBIOALPS Medical Breakthroughs ETF | Biotech & Health Innovation | 19% | 0.50% | $200M | +34.6% | — | side by side |
| PBEInvesco Biotechnology & Genome ETF | Biotech & Health Innovation | 15% | 0.58% | $422M | +34.5% | 1.38% | side by side |
| FBTFirst Trust NYSE Arca Biotechnology Index Fund | Biotech & Health Innovation | 12% | 0.55% | $2.9B | +41.3% | — | side by side |
| XBIState Street SPDR S&P Biotech ETF | Biotech & Health Innovation | 12% | 0.35% | $9.9B | +45.8% | 0.35% | side by side |
| PSCHInvesco S&P SmallCap Health Care ETF | Health Care | 11% | 0.29% | $179M | +22.8% | 0.00% | side by side |
Overlap is the sum of the smaller of the two weights across every shared holding. Try any combination in the overlap tool.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.